Purchase this article with an account.
D. Meller, T. Fuchsluger, H. Westekemper, M. Pauklin, K.-P. Steuhl; Autologous and Allogenic Transplantation of Cultivated Corneal Epithelial Equivalents on Intact Amniotic Membrane for the Treatment of Severe Ocular Surface Disease.. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5716. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the use of ex-vivo cultivated corneal epithelial equivalents on intact amniotic membrane for the treatment of severe ocular surface disease.
We performed ex-vivo expansion of corneal / limbal epithelial cells from a small limbal biopsy (1x2mm) harvested from the fellow eye or from a healthy donor. Ex-vivo expansion was performed on intact AM. Two weeks later, following laminar keratectomy, the AM with the expanded corneal epithelial cells were placed on the corneal defect. A second AM was used as protective patch. In case of allogenic donor source all but one patient were treated with cyclosporin A as a systemic immunosuppression. Postoperative follow-up included slit-lamp examinations with fluorescein staining, as well as photographic documentation. Graft integrity and postoperative complications were evaluated.
Follow-up was 18 ± 12.1 months. Thirty five patients (mean age 46,4 ± 17,3 years) underwent autologous (n=24) or allogenic (n=14) ex-vivo expansion and transplantation of corneal epithelial cells, which were expanded on intact amniotic membrane (AM). Limbal stem cell deficiency (LSCD) resulted from following chemical burn (n=18), thermal burns (n=2), pterygium, numerous surgeries at the limbus (n=2), GvhD (n=1), pemphigoid (n=1), epidermolysis (n=1), ocular perforating trauma (n=1), MMC toxicity (n=1), and chlamydia infection (n=1). At the present state of the follow-up 83,3% of the autologous transplantations and 69% of the allogenic transplantations were graded as successful and showed an improvement of vision acuity by > or = 2 lines. These patients showed a clear, smooth, and stable corneal ocular surface without recurrence of LSCD. In the autologous group loss of graft integrity were noted in 4 cases, in the allogenic group graft failure was noted in 2 cases whereas graft rejection occurred in 2 cases.
The method of ex-vivo expansion of autologous-serum derived cultivated corneal epithelial equivalents harvested from the fellow eye, cadaveric or living-related donors offers a feasible possibility to reconstruct the ocular surface in a variety of states causing uni- or bilateral limbal stem cell deficiency. Further long term follow-up is necessary to conclude on whether the repopulation of the limbal epithelial stem cells, which is clinically apparent, is also effective in order to prevent late recurrences of the disease.
This PDF is available to Subscribers Only